Found 5 hits in this display Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Peroxisome proliferator-activated receptor gamma
(Homo sapiens (Human)) | BDBM50471946
(CHEMBL149715)Show SMILES Cc1oc(nc1CCOc1ccc(C[C@H](Nc2ccccc2C(=O)c2ccccc2)C(O)=O)cc1)N1CCCCC1 Show InChI InChI=1S/C33H35N3O5/c1-23-28(35-33(41-23)36-19-8-3-9-20-36)18-21-40-26-16-14-24(15-17-26)22-30(32(38)39)34-29-13-7-6-12-27(29)31(37)25-10-4-2-5-11-25/h2,4-7,10-17,30,34H,3,8-9,18-22H2,1H3,(H,38,39)/t30-/m0/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| 170 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Glaxo Wellcome Research and Development
Curated by ChEMBL
| Assay Description Inhibition by 50% of in vitro binding to Peroxisome proliferator activated receptor gamma |
J Med Chem 41: 5037-54 (1998)
Article DOI: 10.1021/jm980413z BindingDB Entry DOI: 10.7270/Q2J38W9F |
More data for this Ligand-Target Pair | |
Peroxisome proliferator-activated receptor alpha
(Homo sapiens (Human)) | BDBM50471946
(CHEMBL149715)Show SMILES Cc1oc(nc1CCOc1ccc(C[C@H](Nc2ccccc2C(=O)c2ccccc2)C(O)=O)cc1)N1CCCCC1 Show InChI InChI=1S/C33H35N3O5/c1-23-28(35-33(41-23)36-19-8-3-9-20-36)18-21-40-26-16-14-24(15-17-26)22-30(32(38)39)34-29-13-7-6-12-27(29)31(37)25-10-4-2-5-11-25/h2,4-7,10-17,30,34H,3,8-9,18-22H2,1H3,(H,38,39)/t30-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| <3.02E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Glaxo Wellcome Research and Development
Curated by ChEMBL
| Assay Description Tested in vitro for inhibiting the 50% binding of Peroxisome proliferator activated receptor alpha |
J Med Chem 41: 5037-54 (1998)
Article DOI: 10.1021/jm980413z BindingDB Entry DOI: 10.7270/Q2J38W9F |
More data for this Ligand-Target Pair | |
Peroxisome proliferator-activated receptor gamma
(Homo sapiens (Human)) | BDBM50471946
(CHEMBL149715)Show SMILES Cc1oc(nc1CCOc1ccc(C[C@H](Nc2ccccc2C(=O)c2ccccc2)C(O)=O)cc1)N1CCCCC1 Show InChI InChI=1S/C33H35N3O5/c1-23-28(35-33(41-23)36-19-8-3-9-20-36)18-21-40-26-16-14-24(15-17-26)22-30(32(38)39)34-29-13-7-6-12-27(29)31(37)25-10-4-2-5-11-25/h2,4-7,10-17,30,34H,3,8-9,18-22H2,1H3,(H,38,39)/t30-/m0/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | n/a | n/a | 51 | n/a | n/a | n/a | n/a |
Glaxo Wellcome Research and Development
Curated by ChEMBL
| Assay Description Tested functionally in vitro for inducing 50% of the maximum alkaline phosphate activity (Transactivation) against Peroxisome proliferator activated ... |
J Med Chem 41: 5037-54 (1998)
Article DOI: 10.1021/jm980413z BindingDB Entry DOI: 10.7270/Q2J38W9F |
More data for this Ligand-Target Pair | |
Peroxisome proliferator-activated receptor gamma
(Homo sapiens (Human)) | BDBM50471946
(CHEMBL149715)Show SMILES Cc1oc(nc1CCOc1ccc(C[C@H](Nc2ccccc2C(=O)c2ccccc2)C(O)=O)cc1)N1CCCCC1 Show InChI InChI=1S/C33H35N3O5/c1-23-28(35-33(41-23)36-19-8-3-9-20-36)18-21-40-26-16-14-24(15-17-26)22-30(32(38)39)34-29-13-7-6-12-27(29)31(37)25-10-4-2-5-11-25/h2,4-7,10-17,30,34H,3,8-9,18-22H2,1H3,(H,38,39)/t30-/m0/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | n/a | n/a | 550 | n/a | n/a | n/a | n/a |
Glaxo Wellcome Research and Development
Curated by ChEMBL
| Assay Description Ability to promote differentiation of C3H10T1/2 stem cells to adipocytes using lipogenesis assay mediated through activation of Peroxisome proliferat... |
J Med Chem 41: 5037-54 (1998)
Article DOI: 10.1021/jm980413z BindingDB Entry DOI: 10.7270/Q2J38W9F |
More data for this Ligand-Target Pair | |
Peroxisome proliferator-activated receptor alpha
(Homo sapiens (Human)) | BDBM50471946
(CHEMBL149715)Show SMILES Cc1oc(nc1CCOc1ccc(C[C@H](Nc2ccccc2C(=O)c2ccccc2)C(O)=O)cc1)N1CCCCC1 Show InChI InChI=1S/C33H35N3O5/c1-23-28(35-33(41-23)36-19-8-3-9-20-36)18-21-40-26-16-14-24(15-17-26)22-30(32(38)39)34-29-13-7-6-12-27(29)31(37)25-10-4-2-5-11-25/h2,4-7,10-17,30,34H,3,8-9,18-22H2,1H3,(H,38,39)/t30-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a |
Glaxo Wellcome Research and Development
Curated by ChEMBL
| Assay Description In vitro transactivation of Peroxisome proliferator activated receptor alpha. |
J Med Chem 41: 5037-54 (1998)
Article DOI: 10.1021/jm980413z BindingDB Entry DOI: 10.7270/Q2J38W9F |
More data for this Ligand-Target Pair | |